MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Research

Home
Research
lifestyle

Alternative Treatment Approaches in MS Reviewed

MStranslate
August 29, 2017
Lifestyle, Research, Treatments
2 Comments
Across the last few weeks, the MStranslate Facebook page has placed a large focus on lifestyle modifications and how they can be used to help manage multiple sclerosis. As well as gauging how members of the MS...
fatigue

Improving Fatigue: A Goal for New MS Treatments?

MStranslate
August 22, 2017
Fatigue, Research, Symptoms, Treatments
1 Comment
“Doing the little things can make a big difference” - Yogi Berra We constantly marvel at the hard-work, dedication and perseverance of multiple sclerosis researchers around the world.  It is through...
vitamin D

Multiple Sclerosis, Vitamin D & Bone Health

MStranslate
July 24, 2017
Lifestyle, Research, Vitamin D
Research Summary: High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomised controlled trial There has been a lot of online coverage during the past two...
medicinal cannabis

Medicinal Cannabis for Multiple Sclerosis

MStranslate
July 14, 2017
Research, Treatments
1 Comment
Firstly, we would like to thank everyone who contributed to last week's poll gauging the community's interest in access to medicinal cannabis for the management of multiple sclerosis.  Considering the...
MIS416

MIS416 Multiple Sclerosis Trial Results

MStranslate
June 28, 2017
MIS416, Research, Treatments
On Tuesday, Innate Immunotherapeutics released a report outlining the first set of results from their Phase 2b trial on the use of their compound, MIS416, in people with secondary progressive multiple...
interferon-beta

Health Impacts of Interferon-beta Use in MS

MStranslate
May 16, 2017
Interferon-beta, Research, Treatments
Research Summary: Evaluating the safety of β-interferons in MS Research from the University of British Columbia has looked at the long-term health effects of interferon-beta treatment in people with...
statins

Secondary Progressive Multiple Sclerosis & Statins

MStranslate
May 15, 2017
Research, Treatments
There has been a lot of media attention recently on a trial testing statins as a treatment for multiple sclerosis (MS).  The study is being led by University College London and will involve over 1100 people...
Laquinimod

Multiple Sclerosis Clinical Trial Update: Laquinimod

MStranslate
May 9, 2017
Clinical Trials, Laquinimod, Research
What is laquinimod? Laquinimod is a once-daily oral medication that has been developed and tested for the treatment of relapsing-remitting multiple sclerosis (RRMS) and primary progressive MS (PPMS). The...
BMI

BMI & Lipid Levels Impact MS Progression

MStranslate
April 26, 2017
Diet, Lifestyle, Research
2 Comments
Research Summary: An adverse lipid profile and increased levels of adiposity significantly predict clinical course after a first demyelinating event An increasing emphasis is being placed on how lifestyle...

Multiple Sclerosis: One Disease, Many Causes?

MStranslate
April 18, 2017
Research, Understanding Science
1 Comment
In one of our recent Facebook Live Q&A sessions, I was asked what I thought the biggest hurdle was that needed to be overcome in multiple sclerosis research.  Whilst funding problems are something that we...
  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 16

Recent Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Recent Comments

  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date
  • Treatment With Gut Bacteria Shows Benefits In New Study on Gut Bacteria in People Living with RRMS
  • Community Q&A: COVID-19 Vaccines & Multiple Sclerosis on Community Q&A: The Blood-Brain Barrier
  • Community Q&A: Why Don't We Have A Multiple Sclerosis Cure? on Community Q&A: COVID-19 Vaccines & MS
  • Tim Little on FAKE NEWS ALERT: COVID Vaccines & MS

Calendar

July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Jun    

Archives

Categories

Posts

  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.